Waters WAT · USD
Health Care · Life Sciences Tools & Services · US listing · 🇺🇸 United States
S&P 500
476.70
+4.17%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Waters
From its filings with the US Securities and Exchange Commission
Waters is based in Milford, Massachusetts and is incorporated in Delaware. Its shares trade on NYSE under the ticker WAT. It is a member of the S&P 500. The SEC classifies its business as laboratory analytical instruments. In the fiscal year to 31 December 2025, it reported revenue of $3.17bn and net income of $642.6m. At that date it held total assets of $5.08bn and shareholders' equity of $2.56bn.
Waters Corporation (the “Company,” “we,” “our,” or “us”), a global leader in analytical instruments and software, has pioneered innovations in chromatography, mass spectrometry and thermal analysis serving life, materials and food sciences for more than 65 years. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (“HPLC”), ultra-performance liquid chromatography (“UPLC” and together with HPLC, referred to as “LC”) and mass spectrometry (“MS”) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that are frequently employed together (“LC-MS”) and sold as integrated instrument systems using common software platforms.
The Company’s products are used by pharmaceutical, clinical, biochemical, industrial, nutritional safety, environmental, academic and governmental customers working in research and development, quality assurance and other laboratory applications. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS technology, principally in conjunction with chromatography, is employed in drug discovery and development, including clinical trial testing, the analysis of proteins in disease processes (known as “proteomics”), nutritional safety analysis and environmental testing.
Quoted from its 10-K, filed 23 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 17 Nov 1995
- Employees
- 7,900
- Website
- waters.com/nextgen/us/en.html ↗
- Head office
- 34 MAPLE ST, MILFORD, MA, 01757
- Incorporated in
- DE
- Classification
- Laboratory Analytical Instruments
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Dr. Flemming OrnskovIndependent Chairman of the Board$480,157
- Dr. Udit BatraPresident, Chief Executive Officer, Director, since 2020$11.1m
- Mr. Amol ChaubalChief Financial Officer, Senior Vice President$3.2m
- Ms. Jianqing BennettSenior Vice President - TA Instruments Division and Clinical Business Unit$2.5m
- Mr. Robert CarpioSenior Vice President - Waters Division$1.9m
- Ms. Linda BaddourIndependent Director$336,157
- Mr. Daniel BrennanIndependent Director$321,157
- Mr. Richard FearonIndependent Director$319,657
- Dr. Pearl HuangIndependent Director$323,657
- Ms. Heather KnightIndependent Director$128,640
- Mr. Christopher KueblerIndependent Director$328,657
- Mr. Mark VergnanoIndependent Director$316,657
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 92
- Environment
- 99
- Social
- 99
- Governance
- 78
- Direct emissions (scope 1)
- 12,659.53 t
- Energy emissions (scope 2)
- 17,542.43 t
- Value chain emissions (scope 3)
- 189,019.37 t
- Women in the workforce
- 32.3%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Waters Corp has several notable strengths that contribute to its success in the market. Firstly, the company has a strong reputation and brand recognition within the scientific equipment industry. This enables Waters Corp to attract and retain a loyal customer base.
- Secondly, the company has a diverse portfolio of high-quality products. Waters Corp offers a wide range of innovative scientific instruments and analytical technologies, which cater to the varied needs of its customers. This product diversity provides a competitive advantage in the market.
- Additionally, Waters Corp has a strong global presence and distribution network. This allows the company to effectively reach customers worldwide, ensuring a broad market reach and increased sales opportunities. The global presence also helps the company stay updated with international industry trends and regulatory standards.
Weaknesses
- Despite its strengths, Waters Corp also faces certain weaknesses that need to be addressed. One weakness is the relatively high pricing of its products compared to some competitors. This may limit market penetration and pose challenges in price-sensitive segments.
- Another weakness is the company's dependence on a few key suppliers for critical components. Any disruption in the supply chain can have a negative impact on production, leading to delays or potential product shortages. Diversifying supplier sources could mitigate this risk.
Opportunities
- The scientific equipment industry presents several opportunities for Waters Corp. One opportunity lies in the increasing demand for advanced analytical technologies in emerging markets. By focusing on expanding its presence in these markets, the company can tap into new customer bases and drive revenue growth.
- Another opportunity is the growing emphasis on research and development in various industries. Waters Corp can capitalize on this trend by investing in the development of cutting-edge products and solutions, thus maintaining a competitive edge in the market.
Threats
- Waters Corp faces certain threats that could impact its business operations. One significant threat is intense competition from other scientific equipment manufacturers. Rival companies may offer similar or alternative products at lower prices or with enhanced features, posing a challenge to Waters Corp's market share.
- Additionally, regulatory changes and compliance requirements in different countries can pose a threat to Waters Corp's operations. Compliance with evolving regulations may require additional investments or modifications to the company's products, which could impact profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.